John A. Pieper - Concepedia

Author

John A. Pieper

University of North Carolina at Chapel Hill

Also Known As

J A Pieper, J PIEPER, J. A. Pieper, J. Pieper, John A Pieper, John A. Pieper, John Pieper, John Pieper (Chair), John A Pieper

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Tennessee Health Science Center University of Florida National Institute of Environmental Health Sciences University of Tennessee at Knoxville

About

John A. Pieper is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	747
2	Health Sciences	1	1	37
3	Natural Sciences	1	1	102
4	Public Health	1	1	13
5	Allergy	1	1	102

John A. Pieper

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Tolbutamide, Flurbiprofen, and Losartan as Probes of CYP2C9 Activity in Humans Craig R. Lee, John A. Pieper, Alan L. Hinderliter, The Journal of Clinical Pharmacology Metabolomic ProfilingPharmacotherapyCyp2c9 ActivityFormation ClearanceExperimental Pharmacology	2003	102
Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers* Kristin Williamson, J. Herbert Patterson, Robert H. McQueen, Clinical Pharmacology & Therapeutics	1998	97
Altered protein binding of etoposide in patients with cancer Clinton F. Stewart, John A. Pieper, Susan G. Arbuck, Clinical Pharmacology & Therapeutics	1989	80
Overview of niacin formulations: Differences in pharmacokinetics, efficacy, and safety John A. Pieper American Journal of Health-System Pharmacy Pharmaceutical SciencePharmacological StudyMedicineIntermediate Dissolution RateDissolution Rates	2003	77
Differences in flurbiprofen pharmacokinetics between CYP2C91/1, 1/2, and 1/3 genotypes Craig R. Lee, John A. Pieper, Reginald F. Frye, European Journal of Clinical Pharmacology Molecular PharmacologyPharmacokinetic ModelingPharmacologyFlurbiprofen PharmacokineticsPharmacotherapy	2003	64
Factors Influencing Serum Protein Binding of Lidocaine in Humans Patrick J. McNamara, Richard L. Slaughter, John A. Pieper, Anesthesia & Analgesia Protein ChemistryBiochemistryMedicineBioanalysisSerum Protein Binding	1981	62
Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan Jeannine S. McCune, Celeste Lindley, Jodi L. Decker, The Journal of Clinical Pharmacology	2001	59
Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in <i>CYP2C9*1</i> heterozygotes Craig R. Lee, John A. Pieper, Alan L. Hinderliter, Clinical Pharmacology & Therapeutics	2002	55
Understanding niacin formulations. John A. Pieper PubMed Niacin ErLipid PreparationPharmaceutical SciencePharmaceutical ChemistrySr Formulations	2002	51
Evaluation of potential losartan‐phenytoin drug interactions in healthy volunteers* Tracy L. Fischer, John A. Pieper, Donald W. Graff, Clinical Pharmacology & Therapeutics	2002	48

Page 1